Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Piccini

Showing results (11-20 of 662) with videos related to

Pageof 67
Sort By:
JACC. Heart Failure|April 28, 2022
Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?Jonathan P Piccini, Kelly Arps
European Heart Journal|November 29, 2017
Improving outcomes after catheter ablation of atrial fibrillation: better patient selection, better procedure, or both?Jonathan P Piccini, Paulus Kirchhof
Heart Rhythm|July 23, 2018
Atrial fibrillation and obstructive lung disease: Don't fear the β-blockerZak Loring, Jonathan P Piccini
Lancet (London, England)|August 26, 2016
Rhythm control in atrial fibrillationJonathan P Piccini, Laurent Fauchier
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 5, 2021
Long-term oral anticoagulant after catheter ablation for atrial fibrillationDerek Chew, Jonathan P Piccini
Heart (British Cardiac Society)|December 22, 2022
Women, men and the safety gap after catheter ablation of atrial fibrillationKelly Arps, Jonathan P Piccini
European Journal of Preventive Cardiology|February 21, 2021
The reward of understanding risk in atrial fibrillationZak Loring, Jonathan P Piccini
JACC. Heart Failure|April 28, 2023
Catheter Ablation of Atrial Fibrillation in Persons With HFpEF: We Can All Breathe Easier Now!Anita Deswal, Jonathan P Piccini
Evidence-Based Medicine|February 21, 2012
For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleedingMatthew Sherwood, Jonathan P Piccini
Heart Failure Clinics|July 2, 2013
Optimal utilization and management of implanted cardiac rhythm devices in patients hospitalized for heart failureTiffany Randolph, Jonathan P Piccini
Pageof 67

Showing results (11-20 of 662) with videos related to

Sort By:
Pageof 67
JACC. Heart Failure|April 28, 2022
Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?Jonathan P Piccini, Kelly Arps
European Heart Journal|November 29, 2017
Improving outcomes after catheter ablation of atrial fibrillation: better patient selection, better procedure, or both?Jonathan P Piccini, Paulus Kirchhof
Heart Rhythm|July 23, 2018
Atrial fibrillation and obstructive lung disease: Don't fear the β-blockerZak Loring, Jonathan P Piccini
Lancet (London, England)|August 26, 2016
Rhythm control in atrial fibrillationJonathan P Piccini, Laurent Fauchier
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 5, 2021
Long-term oral anticoagulant after catheter ablation for atrial fibrillationDerek Chew, Jonathan P Piccini
Heart (British Cardiac Society)|December 22, 2022
Women, men and the safety gap after catheter ablation of atrial fibrillationKelly Arps, Jonathan P Piccini
European Journal of Preventive Cardiology|February 21, 2021
The reward of understanding risk in atrial fibrillationZak Loring, Jonathan P Piccini
JACC. Heart Failure|April 28, 2023
Catheter Ablation of Atrial Fibrillation in Persons With HFpEF: We Can All Breathe Easier Now!Anita Deswal, Jonathan P Piccini
Evidence-Based Medicine|February 21, 2012
For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleedingMatthew Sherwood, Jonathan P Piccini
Heart Failure Clinics|July 2, 2013
Optimal utilization and management of implanted cardiac rhythm devices in patients hospitalized for heart failureTiffany Randolph, Jonathan P Piccini
Pageof 67